A bill for an act relating to manufacturers and distributors of 340B drugs.

HF 2009 defines key terms related to 340B drugs (prescription drugs sold at reduced prices under federal law) and prohibits drug manufacturers or distributors from interfering with covered entities (like hospitals or clinics) acquiring these drugs or delivering them to contract pharmacies. It specifically bans manufacturers or distributors from denying, restricting, or hindering this process unless federal health authorities have already prohibited it. The bill directly affects healthcare providers using 340B pricing and the pharmacies that serve them. It ensures that state-level rules align with federal 340B program requirements by preventing unnecessary barriers to accessing these discounted drugs.